-
Fulvestrant, sold
under the
brand name
Faslodex among others, is an
antiestrogenic medication used to
treat hormone receptor (HR)-positive metastatic...
-
suppressing tumor growth. A
common SERD used in
clinical practice is
fulvestrant.
Fulvestrant is
administered as an
intramuscular injection and is indicated...
- capivasertib, used
alongside fulvestrant, was
approved by the NHS in the UK. Capivasertib, used in
combination with
fulvestrant (Faslodex), is
indicated for...
- ZB716, also
known as
fulvestrant-3-boronic acid, is a synthetic, steroidal,
orally active antiestrogen which is
under development for the
treatment of...
- used to
treat certain types of
breast cancer. It is used
together with
fulvestrant. It is
taken by mouth. It is
marketed by Novartis.
Common side effects...
-
tamoxifen is no
longer effective.
Fulvestrant is a SERD drug that acts by
damaging and
blocking estrogen receptors.
Fulvestrant is
currently only
approved by...
-
palbociclib is
prescribed as a
combination therapy with
either letrozole or
fulvestrant.
Patients should also not
consume CYP3A
inhibitors or
inducers while...
- ER
silent antagonist and
selective estrogen receptor degrader (SERD)
fulvestrant,
aromatase inhibitors (AIs) like anastrozole, and
antigonadotropins including...
-
clinical trials: The
phase III
trial BELLE-2
compared buparlisib +
fulvestrant with
fulvestrant alone in
patients with
advanced or
metastatic HER2-negative,...
-
phase III
trials BELLE-2 and BELLE-3
comparing buparlisib +
fulvestrant with
fulvestrant alone in
patients with
breast cancer both
showed excessive side...
